# Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone

> **NCT02617628** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 146 (actual)

## Conditions studied

- Opiate Dependence

## Interventions

- **DRUG:** extended release naltrexone

## Key facts

- **NCT ID:** NCT02617628
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2021-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02617628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02617628, "Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02617628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*